0.57

0.75% -0.0042

Immunoprecise Antibodies Ltd (IPA)

Overview News Price History Option Chain Why IPA Down? Discussions Forecast Stock Split

Immunoprecise Antibodies Ltd stock is traded at $0.57, with a volume of 134.26K. It is down -0.75% in the last 24 hours and up +30.11% over the past month. ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

Previous Close:

$0.5742

Open:

$0.571

24h Volume:

134.26K

Relative Volume:

0.08

Market Cap:

$25.91M

Revenue:

$16.77M

Net Income/Loss:

$-11.87M

P/E Ratio:

-1.202

EPS:

-0.4742

Net Cash Flow:

$-5.90M

1W Performance:

+2.30%

1M Performance:

+30.11%

6M Performance:

+49.97%

1Y Performance:

-48.19%

1-Day Range:

$0.56

$0.58

1-Week Range:

$0.51

$0.58

52-Week Range:

$0.30

$1.14

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name

Immunoprecise Antibodies Ltd

Sector

Healthcare (1177)

Industry

Biotechnology (671)

Phone

Address

Employee

101

Twitter

Next Earnings Date

2024-09-16

Latest SEC Filings

IPA's Discussions on Twitter

Compare IPA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IPA Immunoprecise Antibodies Ltd	0.5662	22.38M	16.77M	-11.87M	-5.90M	-0.4742
ONC Beone Medicines Ltd Adr	245.47	25.81B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	443.48	111.46B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.31	40.37M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.15	6.19B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	489.62	64.44B	14.09B	4.50B	2.96B	39.28

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-22	Initiated	H.C. Wainwright	Buy
Oct-25-21	Initiated	The Benchmark Company	Buy

Immunoprecise Antibodies Ltd Stock (IPA) Latest News

May 24, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Rating Upgraded by Wall Street Zen - Defense World

May 24, 2025

May 21, 2025

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Eng - GuruFocus

May 21, 2025

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts - Yahoo Finance

May 21, 2025

May 20, 2025

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference | IPA Stock News - GuruFocus

May 20, 2025

ImmunoPrecise Antibodies to Present at Maxim Group’s 2025 Virtual Tech Conference - TipRanks

May 20, 2025

AI Breakthrough: ImmunoPrecise CEO Reveals Next-Gen Biotherapeutics Strategy at Major Tech Conference - Stock Titan

May 20, 2025

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech Conference - Yahoo Finance

May 20, 2025

What's Going on With Apple Stock? - The Globe and Mail

May 20, 2025

May 12, 2025

ImmunoPrecise Antibodies (IPA) Showcases Breakthrough in Epitope Mapping | IPA Stock News - GuruFocus

May 12, 2025

ImmunoPrecise Antibodies’ LENSai Platform Revolutionizes Epitope Mapping - TipRanks

May 12, 2025

IPA's LENSai™ Platform Delivers X-Ray--Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed | IPA Stock News - GuruFocus

May 12, 2025

IPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed - Yahoo Finance

May 12, 2025

May 04, 2025

ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Shares Leap 28% Yet They're Still Not Telling The Full Story - simplywall.st

May 04, 2025

Apr 25, 2025

How ImmunoPrecise Antibodies ($IPA) Uses AI to Transform Antibody-Based Drug Discovery - Podomatic

Apr 25, 2025

Apr 24, 2025

Views of Wall Street’s Leading Experts on ImmunoPrecise Antibodies Ltd - Sete News

Apr 24, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Down 7% – Should You Sell? - Defense World

Apr 24, 2025

Apr 23, 2025

What is going on with ImmunoPrecise Antibodies Ltd? Sentiment Analysis - uspostnews.com

Apr 23, 2025

Apr 22, 2025

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st

Apr 22, 2025

Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com Australia

Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock By Investing.com - Investing.com South Africa

Apr 14, 2025

ImmunoPrecise Antibodies’ (IPA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Apr 14, 2025

Apr 12, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI- - GuruFocus

Apr 12, 2025

Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - 01net

Apr 11, 2025

ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing - TipRanks

Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSaitm with FDA's Shift to Non-Animal Testing Methods - Lelezard

Apr 11, 2025

AI Breakthrough: How IPA's LENSai Platform Leads FDA's Historic Shift from Animal Testing - Stock Titan

Apr 11, 2025

Apr 10, 2025

ImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody Discovery - TipRanks

Apr 10, 2025

Apr 04, 2025

HC Wainwright Has Positive Outlook of IPA FY2025 Earnings - Defense World

Apr 04, 2025

Apr 03, 2025

ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Apr 03, 2025

HC Wainwright Has Bearish Forecast for IPA FY2028 Earnings - Defense World

Apr 03, 2025

Apr 02, 2025

ImmunoPrecise Antibodies’ (IPA) “Speculative Buy” Rating Reaffirmed at Benchmark - Defense World

Apr 02, 2025

Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock By Investing.com - Investing.com Australia

Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock - Investing.com

Apr 01, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target Lowered to $5.00 at HC Wainwright - Defense World

Apr 01, 2025

Mar 31, 2025

ImmunoPrecise Antibodies Earnings Call Highlights Growth - TipRanks

Mar 31, 2025

Immunoprecise stock target cut to $5 by H.C. Wainwright - Investing.com Australia

Mar 31, 2025

Mar 30, 2025